Haofei Hong

Key Laboratory Of Carbohydrate Chemistry & Biotechnology
Wuxi, 214122, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Chemoenzymatic synthesis of a CD19/CD20 bispecific nanobody-rhamnose conjugate with reconstituted Fc effector functions for immunotherapy of B-cell malignancies✰.

Chemoenzymatic synthesis of a CD19/CD20 bispecific nanobody-rhamnose conjugate with reconstituted Fc effector functions for immunotherapy of B-cell malignancies✰.

Journal: Journal of pharmaceutical sciences

Published: February 11, 2026

Chemoenzymatic Synthesis of Nanobody-Peptide Conjugates Capable of Harnessing HBV Vaccine-Induced Antibodies for Cancer Immunotherapy.

Chemoenzymatic Synthesis of Nanobody-Peptide Conjugates Capable of Harnessing HBV Vaccine-Induced Antibodies for Cancer Immunotherapy.

Journal: Bioconjugate chemistry

Published: January 07, 2026

Chemoenzymatic Synthesis of Rhamnolipid-Modified Exendin-4: A Dual Approach for Long-Acting Glycemic Control through Endogenous Antibody Recruitment and Albumin Interaction.

Chemoenzymatic Synthesis of Rhamnolipid-Modified Exendin-4: A Dual Approach for Long-Acting Glycemic Control through Endogenous Antibody Recruitment and Albumin Interaction.

Journal: Journal of medicinal chemistry

Published: October 30, 2025

Modular pentameric protein scaffold based on glutaraldehyde-crosslinked Stx1B for superior multivalent therapeutics.

Modular pentameric protein scaffold based on glutaraldehyde-crosslinked Stx1B for superior multivalent therapeutics.

Journal: International journal of biological macromolecules

Published: October 12, 2025

Repurposing vaccine-induced anti-HBV antibodies for endogenous immunotherapy against EGFR-positive tumors.

Repurposing vaccine-induced anti-HBV antibodies for endogenous immunotherapy against EGFR-positive tumors.

Journal: Chemical communications (Cambridge, England)

Published: September 02, 2025

Engineered Nanobody Chimeras Recruits Anti-HBV Antibodies for Target Cancer Immunotherapy.

Engineered Nanobody Chimeras Recruits Anti-HBV Antibodies for Target Cancer Immunotherapy.

Journal: Journal of medicinal chemistry

Published: August 05, 2025

A modular and universal platform for neutralizing-antibody profiling by quantifying antigen-receptor interactions via qPCR.

A modular and universal platform for neutralizing-antibody profiling by quantifying antigen-receptor interactions via qPCR.

Journal: Analytical biochemistry

Published: May 19, 2025

A Dually Nanobody-Engineered Milk-Derived Extracellular Vesicle Nanomedicine Targeting Tumour-Associated Macrophages and Cancer Cells for Cancer Therapy.

A Dually Nanobody-Engineered Milk-Derived Extracellular Vesicle Nanomedicine Targeting Tumour-Associated Macrophages and Cancer Cells for Cancer Therapy.

Journal: Journal of extracellular vesicles

Published: May 15, 2025

Macrocyclic RGD-peptides with high selectivity for αvβ3 integrin in cancer imaging and therapy.

Macrocyclic RGD-peptides with high selectivity for αvβ3 integrin in cancer imaging and therapy.

Journal: RSC medicinal chemistry

Published: April 02, 2025

In Situ Self-Assembly of Antibody-Rhamnose Complex as a Pre-Targeting Strategy for Enhanced Cancer Immunotherapy.

In Situ Self-Assembly of Antibody-Rhamnose Complex as a Pre-Targeting Strategy for Enhanced Cancer Immunotherapy.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: September 23, 2024

Reconstituting the immune killing functions and improving the pharmacokinetics of nanobodies by rhamnolipid conjugation.

Reconstituting the immune killing functions and improving the pharmacokinetics of nanobodies by rhamnolipid conjugation.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: June 25, 2024

Chemo-Enzymatic Functionalization of Bovine Milk Exosomes with an EGFR Nanobody for Target-specific Drug Delivery.

Chemo-Enzymatic Functionalization of Bovine Milk Exosomes with an EGFR Nanobody for Target-specific Drug Delivery.

Journal: Chembiochem : a European journal of chemical biology

Published: June 13, 2024

Showing 1-12 of 35

Last Updated: 09/26/2026